CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.3B, above the global median of $1.18B
- FinancialsAltman Z-Score 0.64: distress zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.76%Above 5Y avg (0.48%)
Annual Rate
CNY 0.04Paid unknown
Payout Ratio
90.3%High
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.72BCNY1.30B · vs all stocks (USD)
Trailing P/E
66.00xRevenue (TTM)
8.19BCNY1.22B · vs all stocks (USD)
Profit Margin
1.51%Beta
0.2070xvs all stocks
52-Week Change
-11.65%vs all stocks
Forward Annual Dividend Yield
0.76%vs all stocks
Market Capitalization
8.72BCNY1.30B · vs all stocks (USD)
Enterprise Value
19.04BCNY2.84B · vs all stocks (USD)
Trailing P/E
66.00xPrice to Sales (TTM)
0.9683xPrice to Book (MRQ)
1.48xEnterprise to Revenue
2.33xEnterprise to EBITDA
13.15xGross Margin
25.06%Profit Margin
1.51%Operating Margin
6.08%Return on Assets (TTM)
1.51%Return on Equity (TTM)
2.74%Revenue (TTM)
8.19BCNY1.22B · vs all stocks (USD)
Revenue per Share (TTM)
4.77CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-23.50%Gross Profit (TTM)
2.46BCNY366.69M · vs all stocks (USD)
EBITDA (TTM)
1.69BCNY252.40M · vs all stocks (USD)
Net Income (TTM)
123.40MCNY18.43M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-57.00%Operating Cash Flow (TTM)
1.24BCNY184.55M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-95.30MCNY-14.23M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0400CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.76%vs all stocks
Trailing Annual Dividend Rate
0.0350CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.77%vs all stocks
5-Year Average Dividend Yield
0.48%vs all stocks
Payout Ratio
90.28%Minority Interest (Equity)
1.37BCNYFY2025 · Dec 31, 2025Revenue
9.24BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
6.38BCNYFY2025 · Dec 31, 2025Gross Profit
2.87BCNYFY2025 · Dec 31, 2025Operating Income
665.56MCNY99.39M · vs all stocks (USD)
Pre-tax Income
357.41MCNYFY2025 · Dec 31, 2025Income Tax Expense
99.96MCNYFY2025 · Dec 31, 2025Net Income
257.45MCNYFY2025 · Dec 31, 2025EBIT
718.96MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.69BCNYFY2025 · Dec 31, 2025Research & Development
341.00MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.16BCNYFY2025 · Dec 31, 2025Other Operating Expenses
115.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.82MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
361.55MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1070CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1070CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.71BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.71BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
257.45MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-74.40MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
549.35MCNYFY2025 · Dec 31, 2025Free Cash Flow
7.96MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.27BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
257.45MCNYFY2025 · Dec 31, 2025Other Non-cash Items
376.12MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-197.85MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
113.63MCNYFY2025 · Dec 31, 2025Capital Expenditures
-541.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-300.00MCNYFY2025 · Dec 31, 2025Sale of Investments
60.47MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-780.93MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
8.78BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-9.15BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-412.84MCNYFY2025 · Dec 31, 2025Other Financing Charges
462.90MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-318.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.72BSharesUpdated Sep 22, 2026Float Shares
772.03MSharesUpdated Sep 22, 2026% Held by Insiders
59.86%vs all stocks
% Held by Institutions
0.84%vs all stocks
Total Cash (MRQ)
1.18BCNY176.16M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6880CNYUpdated Sep 22, 2026Total Debt (MRQ)
10.94BCNY1.63B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.59xCurrent Ratio (MRQ)
0.7600xBook Value per Share (MRQ)
3.13CNYUpdated Sep 22, 2026Total Assets
21.39BCNY3.19B · vs all stocks (USD)
Total Current Assets
8.13BCNYFY2025 · Dec 31, 2025Total Liabilities
14.51BCNYFY2025 · Dec 31, 2025Total Non-current Assets
13.26BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.11BCNYFY2025 · Dec 31, 2025Total Current Liabilities
12.40BCNYFY2025 · Dec 31, 2025Cash
886.01MCNYFY2025 · Dec 31, 2025Cash Equivalents
655.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.54BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.41BCNYFY2025 · Dec 31, 2025Inventory
2.41BCNYFY2025 · Dec 31, 2025Accounts Payable
2.45BCNYFY2025 · Dec 31, 2025Short-term Debt
9.21BCNYFY2025 · Dec 31, 2025Other Current Liabilities
18.07MCNYFY2025 · Dec 31, 2025Long-term Debt
2.00BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.72BCNYFY2025 · Dec 31, 2025Retained Earnings
-404.61MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.88BCNY1.03B · vs all stocks (USD)
52-Week Low
4.11CNYUpdated Sep 22, 202652-Week High
6.29CNYUpdated Sep 22, 202652-Week Change
-11.65%vs all stocks
Beta
0.2070xvs all stocks
50-Day MA
4.86CNYUpdated Sep 22, 2026200-Day MA
5.16CNYUpdated Sep 22, 2026Avg 10-Day Volume
46.37MSharesUpdated Sep 22, 2026Avg 30-Day Volume
31.30MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.0700CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.64: distress zoneCritical
Altman Z-Score: 0.64
High earnings qualityNotable
Earnings Quality Score: 2.49
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.3B, above the global median of $1.18BNotable
Market cap (USD): 1,301,546,881.963Global Median: 1,180,223,658.953
Revenue is $1.22B, above the global median of $548.88MNotable
Revenue (USD): 1,222,446,478.868Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Bio-Thera Solutions Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Liaoning Chengda Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Sinocare Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Hisun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Weigao Orthopaedic Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Yizhong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Akums Drugs & Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Damora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule